Reaction Details Report a problem with these data
Target
Apelin
Ligand
BDBM610903
Substrate
n/a
Meas. Tech.
Measurement of Apelin Receptor Agonist Activity
EC50
314±n/a nM
Citation
 Ikeda, T; Kobayashi, Y; Miyoshi, N; Suzuki, O; Nagayama, T; Tsuji, T; Smith, LH; Pinkerton, AB Azole derivatives as apelin receptor agonist US Patent  US10626096 Publication Date 4/21/2020 
Target
Name:
Apelin
Synonyms:
APEL | APEL_HUMAN | APJ endogenous ligand | APLN | Apelin-13 | Apelin-28 | Apelin-31 | Apelin-36
Type:
PROTEIN
Mol. Mass.:
8579.06
Organism:
Homo sapiens (Human)
Description:
ChEMBL_108275
Residue:
77
Sequence:
MNLRLCVQALLLLWLSLTAVCGGSLMPLPDGNGLEDGNVRHLVQPRGSRNGPGPWQGGRRKFRRQRPRLSHKGPMPF
  
Inhibitor
Name:
BDBM610903
Synonyms:
5-({[4-(2,6-Dimethoxyphenyl)-5-(5-methylfuran-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)pyrazolo[1,5-a]pyrimidin-7(4H)-one | US10626096, Example 16
Type:
Small organic molecule
Emp. Form.:
C22H20N6O4S
Mol. Mass.:
464.497
SMILES:
COc1cccc(OC)c1-n1c(SCc2cc(=O)n3nccc3[nH]2)nnc1-c1ccc(C)o1 |(6.72,1.01,;5.18,1.01,;4.41,-.32,;5.18,-1.65,;4.41,-2.99,;2.87,-2.99,;2.1,-1.65,;.56,-1.65,;-.21,-2.99,;2.87,-.32,;2.1,1.01,;.56,1.01,;-.53,-.07,;-2.02,.32,;-3.1,-.76,;-4.59,-.37,;-5.68,-1.46,;-7.17,-1.06,;-5.28,-2.94,;-6.12,-4.23,;-5.15,-5.43,;-3.71,-4.88,;-3.8,-3.34,;-2.71,-2.25,;.08,2.48,;1.33,3.38,;2.58,2.48,;4.06,2.88,;5.31,1.97,;6.56,2.88,;6.08,4.34,;7.17,5.43,;4.54,4.34,)|
Structure:
Search PDB for entries with ligand similarity: